Home82P • FRA
add
Pacira Biosciences Inc
Previous close
€18.60
Day range
€18.80 - €18.90
Year range
€15.10 - €26.20
Market cap
966.73M USD
Avg Volume
3.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 181.10M | 1.73% |
Operating expense | 128.69M | 27.59% |
Net income | -4.85M | -125.66% |
Net profit margin | -2.68 | -125.26% |
Earnings per share | 0.74 | -16.85% |
EBITDA | 36.46M | -26.85% |
Effective tax rate | -151.53% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 445.86M | 10.30% |
Total assets | 1.54B | -6.65% |
Total liabilities | 779.50M | 1.56% |
Total equity | 757.77M | — |
Shares outstanding | 44.93M | — |
Price to book | 1.10 | — |
Return on assets | 1.46% | — |
Return on capital | 1.62% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -4.85M | -125.66% |
Cash from operations | 12.01M | -77.44% |
Cash from investing | 62.16M | 508.56% |
Cash from financing | -57.50M | -330.20% |
Net change in cash | 16.87M | -73.22% |
Free cash flow | 8.24M | -81.49% |
About
Founded
2006
Headquarters
Website
Employees
789